These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8384458)

  • 1. Susceptibility pattern of Scandinavian Francisella tularensis isolates with regard to oral and parenteral antimicrobial agents.
    Scheel O; Hoel T; Sandvik T; Berdal BP
    APMIS; 1993 Jan; 101(1):33-6. PubMed ID: 8384458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial susceptibilities of Austrian Francisella tularensis holarctica biovar II strains.
    Tomaso H; Al Dahouk S; Hofer E; Splettstoesser WD; Treu TM; Dierich MP; Neubauer H
    Int J Antimicrob Agents; 2005 Oct; 26(4):279-84. PubMed ID: 16143497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibility of isolates of Francisella tularensis from Turkey.
    Kiliç S; Celebi B; Acar B; Ataş M
    Scand J Infect Dis; 2013 May; 45(5):337-41. PubMed ID: 23249114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of Francisella tularensis subsp. holarctica strains isolated from humans in the Central Anatolia region of Turkey.
    Yesilyurt M; Kiliç S; Celebi B; Celik M; Gül S; Erdogan F; Ozel G
    J Antimicrob Chemother; 2011 Nov; 66(11):2588-92. PubMed ID: 21856791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of field isolates of Francisella tularensis subsp. holarctica recovered in Spain to several antimicrobial agents.
    García del Blanco N; Gutiérrez Martín CB; de la Puente Redondo VA; Rodríguez Ferri EF
    Res Vet Sci; 2004 Jun; 76(3):195-8. PubMed ID: 15046952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antibiotic susceptibility of Francisella tularensis isolates from Japan.
    Hotta A; Fujita O; Uda A; Sharma N; Tanabayashi K; Yamamoto Y; Yamada A; Morikawa S
    Jpn J Infect Dis; 2013; 66(6):534-6. PubMed ID: 24270145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic susceptibility in vitro of Francisella tularensis subsp. holarctica isolates from Germany.
    Tomaso H; Hotzel H; Otto P; Myrtennäs K; Forsman M
    J Antimicrob Chemother; 2017 Sep; 72(9):2539-2543. PubMed ID: 28605439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardized broth microdilution antimicrobial susceptibility testing of Francisella tularensis subsp. holarctica strains from Europe and rare Francisella species.
    Georgi E; Schacht E; Scholz HC; Splettstoesser WD
    J Antimicrob Chemother; 2012 Oct; 67(10):2429-33. PubMed ID: 22763567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial susceptibility of Francisella tularensis subsp. holarctica strains from Hungary, Central Europe.
    Kreizinger Z; Makrai L; Helyes G; Magyar T; Erdélyi K; Gyuranecz M
    J Antimicrob Chemother; 2013 Feb; 68(2):370-3. PubMed ID: 23065699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of 71 French isolates of Francisella tularensis subsp. holarctica to eight antibiotics and accuracy of the Etest method.
    Valade E; Vaissaire J; Mérens A; Hernandez E; Gros C; Le Doujet C; Paucod JC; Thibault FM; Durand B; Lapalus M; Dupuis I; Caclard A; Vidal DR; Cavallo JD
    J Antimicrob Chemother; 2008 Jul; 62(1):208-10. PubMed ID: 18397924
    [No Abstract]   [Full Text] [Related]  

  • 11. Characteristics of the Turkish isolates of Francisella tularensis.
    Gurcan S; Karabay O; Karadenizli A; Karagol C; Kantardjiev T; Ivanov IN
    Jpn J Infect Dis; 2008 May; 61(3):223-5. PubMed ID: 18503176
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Caspar Y; Maurin M
    Front Cell Infect Microbiol; 2017; 7():122. PubMed ID: 28443249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic susceptibility of Francisella tularensis subsp. holarctica strains isolated from tularaemia patients in France between 2006 and 2016.
    Caspar Y; Hennebique A; Maurin M
    J Antimicrob Chemother; 2018 Mar; 73(3):687-691. PubMed ID: 29253157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
    Gosbell IB; Fernandes LA; Fernandes CJ
    Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals.
    Ikäheimo I; Syrjälä H; Karhukorpi J; Schildt R; Koskela M
    J Antimicrob Chemother; 2000 Aug; 46(2):287-90. PubMed ID: 10933655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility to quinolones of Francisella tularensis subspecies tularensis.
    Johansson A; Urich SK; Chu MC; Sjöstedt A; Tärnvik A
    Scand J Infect Dis; 2002; 34(5):327-30. PubMed ID: 12069013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America.
    Urich SK; Petersen JM
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2276-8. PubMed ID: 18411318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A serological survey of antibodies against Francisella tularensis in some Swedish mammals.
    Mörner T; Sandstedt K
    Nord Vet Med; 1983 Feb; 35(2):82-5. PubMed ID: 6878028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility pattern of Neisseria gonorrhoeae to antimicrobial agents in Dar es Salaam.
    Mbwana J; Mhalu F; Mwakagile D; Masesa J; Moshiro C; Sandstrom E
    East Afr Med J; 1999 Jun; 76(6):330-4. PubMed ID: 10750520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Susceptibility of Francisella tularensis Isolates in the United States, 2009-2018.
    Choat J; Young J; Petersen JM; Dietrich EA
    Clin Infect Dis; 2024 Jan; 78(Suppl 1):S4-S6. PubMed ID: 38294116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.